Clinical Trial Update: Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating soluble beta-glucan (SBG) for chronic diabetic foot ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Soluble Beta-Glucan (SBG) (soluble beta-glucan)

Snippet

Sponsor: Biotec Pharmacon ASA | Conditions: Chronic Diabetic Foot Ulcers | Phase 3 | Status: COMPLETED